Frailty Syndrome in the Elderly: A Real Challenge for Our Society
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 40072
Special Issue Editor
Interests: frailty syndrome; telemonitoring; comprehensive geriatric assessment; telemedicine; hypervitaminosis B12 syn-drome; hematological disease in the elderly; vitamin B12-related diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Described since the 1970s, the frailty syndrome is a dynamic and evolving geriatric concept, involving many dimensions of everyday life and leading to a risk of developing a loss of autonomy. It corresponds to a precarious state of equilibrium combined with a reduction of physiological reserves linked to aging and is responsible for an inability to respond to physical, psychological, or social stress. Its management requires medical, social, and psychological interventions. It is becoming increasingly important that we detect signs of frailty among individuals on the cusp of old age, not only to ensure this population ages “successfully” but also to avoid unnecessary health-related expenses. The main purpose of this call of paper is to study the frailty syndrome as much on the physiopathological mechanisms which govern it, its daily detection in ambulatory medicine (primary care) or in hospital environment by appropriate scales of identification, and the repercussions of this syndrome.
Dr. Abrar-Ahmad Zulfiqar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- frailty syndrome
- scales
- primary care
- physiopathological mechanisms
- inflammaging
- geriatric risk
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.